Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Newer antiarrhythmic drugs.

E L Michelson1, L S Dreifus

  • 1Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania.

The Medical Clinics of North America
|March 1, 1988
PubMed
Summary

This review covers new antiarrhythmic drugs for managing cardiac arrhythmias, including their pharmacology, effects, and clinical use. It aims to guide therapeutic strategies for complex cardiovascular conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme.

Heart (British Cardiac Society)·2006
Same author

The ABC Trial.

Heart disease (Hagerstown, Md.)·2001
Same author

Effects of candesartan cilexetil on health-related quality of life in black patients with systemic hypertension in the ABC Trial.

Heart disease (Hagerstown, Md.)·2001
Same author

Comparative effects of candesartan cilexetil and losartan in patients with systemic hypertension. Candesartan Versus Losartan Efficacy Comparison (CANDLE) Study Group.

Heart disease (Hagerstown, Md.)·2001
Same author

A forced titration study of antihypertensive efficacy of candesartan cilexetil in comparison to losartan: CLAIM Study II.

Journal of human hypertension·2001
Same author

Antihypertensive efficacy of candesartan in comparison to losartan: the CLAIM study.

Journal of clinical hypertension (Greenwich, Conn.)·2001

Area of Science:

  • Cardiovascular Therapeutics
  • Clinical Pharmacology

Background:

  • Cardiac arrhythmias pose significant challenges in cardiovascular therapeutics.
  • Management involves diverse supraventricular and ventricular tachyarrhythmias in patients with varied cardiac conditions and myocardial dysfunction.

Purpose of the Study:

  • To review recently released and promising new antiarrhythmic drugs.
  • To provide a comprehensive overview of their pharmacological and clinical profiles.

Main Methods:

  • Literature review of newer antiarrhythmic agents.
  • Analysis of drug properties including pharmacology, electrophysiology, pharmacokinetics, and clinical effects.

Main Results:

  • Detailed descriptions of drug pharmacology, electrophysiologic actions, pharmacokinetics, metabolism, and hemodynamic effects.
  • Evaluation of antiarrhythmic efficacy, side effects, drug interactions, indications, and dosage.

Conclusions:

  • New antiarrhythmic drugs offer potential advancements in managing complex cardiac arrhythmias.
  • Understanding their comprehensive profiles is crucial for effective therapeutic application.

Related Experiment Videos